We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Hand-Held Blood Analyzer Receives CE Mark

By LabMedica International staff writers
Posted on 15 Dec 2016
Print article
Image: The easy-to-use i-STAT Alinity handheld operates with the advanced technology of single-use i-STAT test cartridges (Photo courtesy of Abbott).
Image: The easy-to-use i-STAT Alinity handheld operates with the advanced technology of single-use i-STAT test cartridges (Photo courtesy of Abbott).
Globally, demand for healthcare is growing as people live longer, chronic diseases are more prevalent and people are more involved in decisions pertaining to their health. As more people access care, health systems, hospitals and other clinical care settings are challenged to keep pace and find resourceful, efficient and cost-effective ways to provide quality care.

In today's pressure-packed healthcare environment, clinicians rely on easy-to-use testing technologies that do not require complex training. Innovative point of care testing tools can help address this need and provide a simpler experience for those who use it, allowing them to accurately diagnose and treat patients faster and more efficiently.

An innovative, handheld blood-testing platform has received the CE Mark and is now for sale in Europe and other countries that recognize CE Mark. The portable device can perform and analyze the largest menu of blood tests on a single device, ranging from blood chemistries to cardiac markers, using only two to three drops of a person's blood. Delivering results in two to 10 minutes, the device equips healthcare professionals with the information they need to make fast and accurate medical decisions without ever leaving their patient's side. Its advanced connectivity features allow testing to be conducted virtually anywhere.

The i-STAT Alinity System (Abbott Point of Care Inc, Princeton, NJ, USA) returns results within two to 10 minutes and can run tests including blood chemistry and cardiac biomarkers. The system features expansive testing menu capabilities to enable the most combinations of tests in a single cartridge and new types of tests in the future, including tests for brain injury, infectious disease and oncology. Advanced quality control features designed with patient safety and regulatory compliance in the forefront; wireless or hard-wired connectivity so healthcare providers can manage diagnostic data and oversight with the broader healthcare system's network.

The system also features a large, bright, color touchscreen with graphics-driven, on-screen guidance and advanced light and sound notifications that alert clinicians with critical information. An ergonomic design with easy-grip handling that is balanced, comfortable and secure and durable materials designed to prevent damage from drops and harsh cleaning substances commonly used in clinical settings.

Matt Bates, PhD, divisional vice president of research and development at Abbott’s Point of Care Diagnostics division, said, “We spent countless hours doing on-the-ground research with doctors, nurses, lab directors, point of care coordinators and other customers from around the world. We asked about their pain points and listened to what they want and need for testing. Using these customer insights, Abbott designed and built i-STAT Alinity for better access, efficiency and speed to improve clinical decision making and positively impact patients' lives.”

Related Links:
Abbott Point of Care
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more